Histopathological Causes of Late Liver Allograft Dysfunction: Analysis at a Single Institution
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: We summarize our experience in the pathological diagnosis of late complications of liver transplantation (LT) to better understand the causes of late allograft dysfunction in a population mostly composed of patients with hepatitis B virus (HBV) infection. Methods: We reviewed 361 post-transplant liver biopsies from 174 patients who underwent LT and first presented with liver function abnormalities 3 months post-procedure. The underlying diseases included HBV-associated liver disease (77%), toxic or alcoholic liver disease (10.3%), hepatitis C virus (HCV)-associated liver disease (8.6%), primary biliary cirrhosis (1.2%), primary sclerosing cholangitis (1.2%), and metabolic disease (1.7%). Results: The three most common late complications were acute rejection (32.5%), recurrent disease (19.1%), and biliary complication (17.1%). Patients who underwent LT for HBV infection or for drug- or alcohol-related liver disease had a lower incidence of recurring disease than those who underwent transplantation for HCV infection. During post-transplantation months 3-12, acute rejection was the most common cause of allograft dysfunction and recurring disease was the leading cause for allograft dysfunction (p=0.039). The two primary causes of late allograft dysfunction have overlapping histological features, although acute rejection more frequently showed bile duct damage and vascular endothelialitis than recurring HBV infection, and recurring HBV infection had more frequent lobular activity and piecemeal necrosis. Conclusions: The causes of late liver allograft dysfunction are closely associated with the original liver diseases and the period after LT. Careful attention is required for differential diagnosis between acute rejection and recurrent HBV.
Abstract
Background: We summarize our experience in the pathological diagnosis of late complications of liver transplantation (LT) to better understand the causes of late allograft dysfunction in a population mostly composed of patients with hepatitis B virus (HBV) infection. Methods: We reviewed 361 post-transplant liver biopsies from 174 patients who underwent LT and first presented with liver function abnormalities 3 months post-procedure. The underlying diseases included HBV-associated liver disease (77%), toxic or alcoholic liver disease (10.3%), hepatitis C virus (HCV)-associated liver disease (8.6%), primary biliary cirrhosis (1.2%), primary sclerosing cholangitis (1.2%), and metabolic disease (1.7%). Results: The three most common late complications were acute rejection (32.5%), recurrent disease (19.1%), and biliary complication (17.1%). Patients who underwent LT for HBV infection or for drug- or alcohol-related liver disease had a lower incidence of recurring disease than those who underwent transplantation for HCV infection. During post-transplantation months 3-12, acute rejection was the most common cause of allograft dysfunction and recurring disease was the leading cause for allograft dysfunction (p=0.039). The two primary causes of late allograft dysfunction have overlapping histological features, although acute rejection more frequently showed bile duct damage and vascular endothelialitis than recurring HBV infection, and recurring HBV infection had more frequent lobular activity and piecemeal necrosis. Conclusions: The causes of late liver allograft dysfunction are closely associated with the original liver diseases and the period after LT. Careful attention is required for differential diagnosis between acute rejection and recurrent HBV.
참고문헌 (22)
- Wiesner RH, "Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome", Hepatology, 28, pp.638~645 (1998)
- Anand AC, "Timing, significance, and prognosis of late acute liver allograft rejection", Transplantation, 60, pp.1098~1103 (1995)
- Desai M, "Chronic liver allograft dysfunction", Transplant Proc, 41, pp.773~776 (2009)
- Wyatt JI, "Liver transplant pathology : messages for the non-specialist", Histopathology, 57, pp.333~341 (2010)
- Neuberger J, "Chronic allograft dysfunction: diagnosis and management. Is it always progressive?", Liver Transpl, 11(Suppl 2), pp.63~68 (2005)
- Adeyi O, "Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation", J Clin Pathol, 63, pp.47~74 (2010)
- Wiesner RH, "Late hepatic allograft dysfunction", Liver Transpl, 7(11 Suppl 1), pp.60~73 (2001)
- Pappo O, "Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation", Am J Surg Pathol, 19, pp.192~206 (1995)
- Chen J, "Hepatitis B immunoglobulins and", or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review, 2010, pp.25, 872~879
- Gurusamy KS, "Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation", Cochrane Database Syst Rev, 8, pp.CD006573~ (2010)
- Lucena JF, "Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections", Sist Sanit Navar, 27(Suppl 2), pp.91~101 (2004)
- Miyagawa-Hayashino A, "Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome", Transpl Int, 22, pp.303~312 (2009)
- Ekong UD, "The long-term liver graft and protocol biopsy: do we want to look? What will we find?", Curr Opin Organ Transplant, 16, pp.505~508 (2011)
- Nakhleh RE, "Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence", Transplant Proc, 37, pp.1240~1242 (2005)
- Evans HM, "Progressive histological damage in liver allografts following pediatric liver transplantation", Hepatology, 43, pp.1109~1117 (2006)
- Hubscher S, "What does the long-term liver allograft look like for the pediatric recipient?", Liver Transpl, 15(Suppl 2), pp.19~24 (2009)
- Blakolmer K, "Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema", Am J Surg Pathol, 23, pp.1328~1339 (1999)
- Neuberger J, "Incidence, timing, and risk factors for acute and chronic rejection", Liver Transpl Surg, 5(4 Suppl 1), pp.30~36 (1999)
- Uemura T, "Late acute rejection after liver transplantation impacts patient survival", Clin Transplant, 22, pp.316~323 (2008)
- Neil DA, "Current views on rejection pathology in liver transplantation", Transpl Int, 23, pp.971~983 (2010)
- Mor E, "Late-onset acute rejection in orthotopic liver transplantation: associated risk factors and outcome", Transplantation, 54, pp.821~824 (1992)
- Demetris AJ, "Recurrent hepatitis B in liver allograft recipients: differentiation between viral hepatitis B and rejection", Am J Pathol, 125, pp.161~172 (1986)